Dac590 is an orally active FTO inhibitor. Dac590 has a robust antiproliferative effect on AML cells, and induces apoptosis and cell cycle G1 arrest by inhibiting oncogenic FTO signaling. Dac590 significantly inhibits tumor growth and prolongs survival with no observed toxicity in acute myeloid leukemia (AML) xenograft mcie model, and shows a synergistic effect combined with Decitabine (HY-A0004)[1].
Molekulargewicht:
390.79
Reinheit:
96.15
CAS Nummer:
[3084407-00-8]
Formel:
C19H16ClFN2O4
Target-Kategorie:
Apoptosis,Fat Mass and Obesity-associated Protein (FTO)
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
